Skip to main navigation
Skip to main content
KASL
Contact us
mobile search button
mobile menu button
Search
Advanced Search
ABOUT
HOME
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Subscription information
Editorial board meeting
Contact us
BROWSE ARTICLES
All issues
Ahead-of-print
Current issue
Article category
Topics
Snapshot
Most viewed articles
Most downloaded articles
Most cited articles
Search
Video abstract
Metrics
FOR CONTRIBUTORS
Publish with
CMH
Instructions for authors
Peer review and publishing
Checklist
E-submission
Copyright transfer agreement
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Subscription information
Editorial board meeting
Contact us
BROWSE ARTICLES
All issues
Ahead-of-print
Current issue
Article category
Topics
Snapshot
Most viewed articles
Most downloaded articles
Most cited articles
Search
Video abstract
Metrics
FOR CONTRIBUTORS
Publish with
CMH
Instructions for authors
Peer review and publishing
Checklist
E-submission
Copyright transfer agreement
Page Path
HOME
Search
Seren M. Gedallovich
WHERE t1.sid in(parameter_dbtbl_author like '%Seren M. Gedallovich%') and t1.xml_status <> 99
2
results for
"Seren M. Gedallovich"
Filter
Article category
Editorial (1)
Reply to Correspondence (1)
Keywords
DAA (2)
Epigenetic (2)
HCV (1)
Hepatitis C (1)
Hepatocellular cancer (1)
More +
Publication year
2024 (2)
Keywords
DAA (2)
Epigenetic (2)
HCV (1)
Hepatitis C (1)
Hepatocellular cancer (1)
Hepatocellular carcinoma (1)
Cancel
Close
Publication Year
2024 (2)
Cancel
Close
Funded articles
Cancel
Close
"Seren M. Gedallovich"
Reply to Correspondence
Viral hepatitis
Reply to correspondence on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”
Seren M. Gedallovich, Paul Y. Kwo
Clin Mol Hepatol
2024;30(4):1050-1052.
Published online July 12, 2024
DOI:
https://doi.org/10.3350/cmh.2024.0546
PDF
5,070
View
39
Download
Editorial
Viral hepatitis
Meeting the challenges of hepatocellular carcinoma post sustained virologic response in the post-direct- acting antiviral era: A path forward: Editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”
Seren M. Gedallovich, Paul Y. Kwo
Clin Mol Hepatol
2024;30(4):677-681.
Published online June 11, 2024
DOI:
https://doi.org/10.3350/cmh.2024.0418
PDF
4,849
View
44
Download
First
Prev
Page
of 1
Next
Last
×
TOP